Trials / Recruiting
RecruitingNCT06719414
Application of Amide Proton Transfer-Weighted Imaging in Predicting Pathological Complete Response After Neoadjuvant Therapy of Rectal Cancer
A Multi-center Study on Amide Proton Transfer-Weighted Imaging in Predicting Pathological Complete Response After Neoadjuvant Therapy of Rectal Cancer
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 320 (estimated)
- Sponsor
- Sixth Affiliated Hospital, Sun Yat-sen University · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The goal of this observational study is to learn about the amide proton transfer-weighted imaging for rectal cancer response assessment after neoadjuvant therapy. The main question it aims to answer is: • Does amide proton transfer-weighted imaging predict the cancer response before surgery? Participants will underwent amide proton transfer-weighted imaging as part of their regular MRI examination.
Conditions
Timeline
- Start date
- 2024-10-22
- Primary completion
- 2027-12-01
- Completion
- 2028-12-01
- First posted
- 2024-12-05
- Last updated
- 2026-01-27
Locations
2 sites across 1 country: China
Source: ClinicalTrials.gov record NCT06719414. Inclusion in this directory is not an endorsement.